Sign up to save your podcasts
Or
Share E121: Obinutuzumab in SLE-LN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E121: Obinutuzumab in SLE-LN
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
View all episodes
By Michael Putman
4.9
111111 ratings
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
483 Listeners
Rheumnow Podcast
117 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,095 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
511 Listeners
ACR on Air
66 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
169 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners